Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-26
2009-10-13
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07601856
ABSTRACT:
The present invention is directed to compounds of Formula I:that are potassium channel modulators and pharmaceutical compositions thereof. The present invention is further directed to methods of treatment using the compounds and pharmaceutical compositions of the invention. The present invention is still further directed to synthetic processes for producing the compounds of the invention.
REFERENCES:
patent: 3498988 (1970-03-01), Houlihan et al.
patent: 3501475 (1970-03-01), Humber
patent: 3501480 (1970-03-01), Humber et al.
patent: 3501481 (1970-03-01), Archibald et al.
patent: 3501497 (1970-03-01), Bell
patent: 3507880 (1970-04-01), Altwicker
patent: 3509134 (1970-04-01), Davis et al.
patent: 3509184 (1970-04-01), Conover et al.
patent: 3511852 (1970-05-01), Roberts et al.
patent: 3514461 (1970-05-01), Albertson
patent: 3518258 (1970-06-01), Von Strandthmann et al.
patent: 3518269 (1970-06-01), Brown et al.
patent: 3528991 (1970-09-01), Bell
patent: 3534037 (1970-10-01), Loev
patent: 3534059 (1970-10-01), Robinson
patent: 3535326 (1970-10-01), Yammamoto et al.
patent: 3538112 (1970-11-01), Bell
patent: 3539557 (1970-11-01), Davis et al.
patent: 3539576 (1970-11-01), Davis et al.
patent: 3539577 (1970-11-01), Davis et al.
patent: 3539588 (1970-11-01), Salley
patent: 3541117 (1970-11-01), Shroff
patent: 3542787 (1970-11-01), Dobson et al.
patent: 3549644 (1970-12-01), Shavel et al.
patent: 3557087 (1971-01-01), Levine
patent: 3557122 (1971-01-01), Shavel et al.
patent: 3558667 (1971-01-01), Mooradian
patent: 3578678 (1971-05-01), Littell et al.
patent: 3579534 (1971-05-01), Littell et al.
patent: 3580926 (1971-05-01), Short
patent: 3584009 (1971-06-01), Gregory
patent: 3590031 (1971-06-01), Levine
patent: 3592824 (1971-07-01), Schut
patent: 3597433 (1971-08-01), Dobson et al.
patent: 3597436 (1971-08-01), Huisman et al.
patent: 3598836 (1971-08-01), Osaka et al.
patent: 3621027 (1971-11-01), Schoen et al.
patent: 3624126 (1971-11-01), Narayanan
patent: 3632591 (1972-01-01), Albertson et al.
patent: 3642785 (1972-02-01), Shen et al.
patent: 3642836 (1972-02-01), Cusic
patent: 3651059 (1972-03-01), Serino et al.
patent: 3652544 (1972-03-01), Levine
patent: 3655697 (1972-04-01), Shen et al.
patent: 3657243 (1972-04-01), Quintilla
patent: 3663607 (1972-05-01), Barrett et al.
patent: 3674875 (1972-07-01), Shen et al.
patent: 3679662 (1972-07-01), Morita et al.
patent: 3682985 (1972-08-01), Bacso et al.
patent: 3687969 (1972-08-01), Alexander et al.
patent: 3689488 (1972-09-01), Dukes
patent: 3691243 (1972-09-01), Fields et al.
patent: 3705906 (1972-12-01), Narayanan et al.
patent: 3706736 (1972-12-01), Jeger et al.
patent: 3711511 (1973-01-01), Jeger et al.
patent: 3717641 (1973-02-01), Koesis et al.
patent: 3718678 (1973-02-01), Farrand et al.
patent: 3723483 (1973-03-01), Coombs
patent: 3726897 (1973-04-01), Schindler
patent: 3733330 (1973-05-01), Schubert et al.
patent: 3759948 (1973-09-01), Shen et al.
patent: 3773940 (1973-11-01), Schindler
patent: 3773949 (1973-11-01), Macelesfield
patent: 3830818 (1974-08-01), Hackmack et al.
patent: 3836671 (1974-09-01), Barrett et al.
patent: 3838135 (1974-09-01), Magnien et al.
patent: 3865830 (1975-02-01), Turkevich et al.
patent: 3865834 (1975-02-01), Schubert et al.
patent: 3883654 (1975-05-01), Hackmack et al.
patent: 3891656 (1975-06-01), Fields
patent: 3928380 (1975-12-01), Bell et al.
patent: 3931288 (1976-01-01), Berger et al.
patent: 3948939 (1976-04-01), Alexander et al.
patent: 3959309 (1976-05-01), Mooradian
patent: 3994887 (1976-11-01), Crooij et al.
patent: 3997519 (1976-12-01), Armbruster
patent: 4018743 (1977-04-01), Kraft et al.
patent: 4046752 (1977-09-01), Hohmann
patent: 4904797 (1990-02-01), Boshagen et al.
patent: 5017597 (1991-05-01), Gillard
patent: 5708187 (1998-01-01), Flaugh
patent: 5846995 (1998-12-01), Flaugh et al.
patent: 5858995 (1999-01-01), Kawai et al.
patent: 6476021 (2002-11-01), Ohashi et al.
patent: 2417677 (2001-07-01), None
patent: 1210638 (1966-02-01), None
patent: 4238553 (1994-05-01), None
patent: 0297651 (1989-01-01), None
patent: 0344015 (1989-11-01), None
patent: 0350129 (1990-01-01), None
patent: 0375045 (1990-06-01), None
patent: 0425906 (1990-10-01), None
patent: 0441517 (1991-08-01), None
patent: 0451634 (1991-10-01), None
patent: 0468785 (1992-01-01), None
patent: 0640592 (1995-03-01), None
patent: 0655451 (1995-05-01), None
patent: 0749962 (1996-12-01), None
patent: 0768309 (1997-04-01), None
patent: 0247266 (1997-12-01), None
patent: 0992240 (2000-04-01), None
patent: 1118322 (2001-07-01), None
patent: 1136072 (2001-09-01), None
patent: 1462103 (2004-09-01), None
patent: 1260768 (1972-01-01), None
patent: 1265627 (1972-03-01), None
patent: 1299041 (1972-12-01), None
patent: 1322512 (1973-07-01), None
patent: 1323302 (1973-07-01), None
patent: 1323491 (1973-07-01), None
patent: 1385620 (1975-02-01), None
patent: 1471847 (1977-04-01), None
patent: 1519495 (1978-07-01), None
patent: 1532684 (1978-11-01), None
patent: 2316405 (1998-02-01), None
patent: 5001032 (1993-01-01), None
patent: 61282384 (1996-12-01), None
patent: WO 2006001318 (2006-05-01), None
patent: WO 90/12569 (1990-11-01), None
patent: WO 92/12144 (1991-07-01), None
patent: WO 93/00086 (1993-01-01), None
patent: WO 94/09009 (1994-04-01), None
patent: WO 94/14773 (1994-07-01), None
patent: WO 94/25461 (1994-11-01), None
patent: WO 95/29907 (1995-11-01), None
patent: WO 98/06717 (1998-02-01), None
patent: WO 98/53819 (1998-12-01), None
patent: WO 99/17755 (1999-04-01), None
patent: WO 99/26946 (1999-06-01), None
patent: WO 99/28319 (1999-06-01), None
patent: WO 99/54295 (1999-10-01), None
patent: WO 00/18391 (2000-04-01), None
patent: WO 00/24727 (2000-05-01), None
patent: WO 00/32195 (2000-06-01), None
patent: WO 00/63171 (2000-10-01), None
patent: WO 01/45685 (2001-06-01), None
patent: WO 01/95903 (2001-12-01), None
patent: WO 02/07713 (2002-01-01), None
patent: WO 02/34237 (2002-05-01), None
patent: WO 02/41918 (2002-05-01), None
patent: WO 02/051806 (2002-07-01), None
patent: WO 2004/069831 (2004-08-01), None
patent: WO 2005/037791 (2005-04-01), None
patent: WO 2006/001318 (2006-01-01), None
Edwards, G., et al., “Pharmacology of the potassium channel openers”,Cardiovasc. Drugs Ther., 9 (Suppl.2): 185-193, 1995.
Foster, D.C., et al., “The effect of potassium channel antagoists on the BRL 34915 activated potassium channel in guinea-pig bladder”,Br. J. Pharmacol., 92:751, 1987.
Brading, A.F., “Ion channels and control of contractile activity in urinary bladder smooth muscle”,JPN J. Pharmacol., 58 (Suppl.2): 120P-127P, 1992.
Malmgren, A., et al., “Effects of cromakalim (BRL 34915) and pinacidil on normal and hypertrophied rat detrusor in vitro”,J. Urol., 143:828-834, 1990.
Grant, T.L., et al., “Effects of K−channel blockers and cromakalim (BRL 34915) on the mechanical activity of guinea pig cetruso smooth muscle”,J. Pharmacol. Exp., Ther., 269(3):1158-1164, 1991.
Malmgren, A., et al., “Effects of pinacidil and cromakalim (BRL 34915) on bladder function in rats with detrusor instability”,J. Urol., 142:1134-1138, 1989.
Wojdan, A., et al., “Comparison of the potassium channel openers ZD6169, celikalim and WAY-133537 on isolated bladder tissue and in vivo bladder instability in the rat”,J. Pharmacol. Exp. Ther., 289(3):1410-1418, 1999.
Wickenden, A.D., et al., “Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels”,Molec. Pharmacol., , 58:591-600, 2000.
Wickenden, A.D., et al., “Characterization of the KCNQ5/Q3 potassium channels expressed in mammalian cells”,Br. J. Pharmacol., 132(2):381-384, 2001.
Rundfeldt, C., et al., “The novel anticonvulant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subuints”,Neurosci. Lett., 282(1-2):73-76, 2000.
Main, M.J., et al., “Modulation of KCNQ2/3potassium channels by the novel anticonvulsant retigabine”,Mol. Pharmacol., 58(2):253-262, 2000.
Sogaard, R., et
Butera John A.
Herbst David R.
McFarlane Geraldine
Sabalski Joan E.
Trybulski Eugene J.
Chandrakumar Nizal S
Pepper Hamilton LLP
Seaman D. Margaret
Wyeth
LandOfFree
Benzofurans as potassium ion channel modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzofurans as potassium ion channel modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzofurans as potassium ion channel modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4120961